ResearcherUniversity of PerugiaActive in the last 2 years
Stefano Fiorucci
Matched on ORCID iD 0000-0003-3816-4222; OpenAlex author ID A5057720130.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 1
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.bcp.2026.117707↗
- Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma. Last author DOI 10.3389/fonc.2023.1140730↗
- Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma. Last author DOI 10.3390/cells11213482↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Cristina Di Giorgio · 3 shared papers, 2022–2026
- Paper LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma. DOI 10.1016/j.bcp.2026.117707↗
- Paper Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancrea… DOI 10.3389/fonc.2023.1140730↗
- Paper Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenoca… DOI 10.3390/cells11213482↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.